Viatris at its annual meeting also named Philippe Martin as chief R&D officer, effective immediately. Martin had worked at Celgene and Schering-Plough.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.41 USD | -1.14% | -5.96% | -3.88% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.88% | 12.39B | |
+38.51% | 727B | |
+31.74% | 594B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.44% | 205B | |
-5.97% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- VTRS Stock
- News Viatris Inc.
- Viatris Inc. Names Philippe Martin as Chief R&D Officer